Octagon Capital Group served as the sole advisor to Harmony Biosciences in connection with its $270 million Equity Financing from investors or affiliates including Paragon Biosciences, Valor Equity Partners, Fidelity Management & Research, HBM Healthcare Investments, Vivo Capital, venBio Partners, Novo Holdings and Nan Fung Life Sciences.